Advertisement

Lipids

, Volume 42, Issue 7, pp 621–627 | Cite as

A Green Tea Catechin Extract Upregulates the Hepatic Low-Density Lipoprotein Receptor in Rats

  • Christina A. BursillEmail author
  • Paul D. Roach
Original Article

Abstract

Green tea extracts have hypocholesterolaemic properties in epidemiological and animal intervention studies. Upregulation of the low-density lipoprotein (LDL) receptor may be one mechanism to explain this as it is the main way cholesterol is removed from the circulation. This study aimed to determine if a green tea extract could upregulate the hepatic LDL receptor in vivo in the rat. A green tea extract (GTE) enriched in its anti-oxidant constituents, the catechins, was fed to rats (n = 6) at concentrations of either 0, 0.5, 1.0 or 2.0% (w/w) mixed in with their normal chow along with 0.25% (w/w) cholesterol for 12 days. Administration of the GTE had no effect on plasma total or LDL cholesterol concentrations but high-density lipoprotein significantly increased (41%; p < 0.05). Interestingly, there was a significant increase in LDL receptor binding activity (2.7-fold) and LDL receptor protein (3.4-fold) in the 2% (w/w) treatment group compared to controls. There were also significant reductions in liver total and unesterified cholesterol (40%). Administration of the GTE significantly reduced cholesterol absorption (24%) but did not affect cholesterol synthesis. These results show that, despite no effect on plasma cholesterol, the GTE upregulated the LDL receptor in vivo. This appears to be via a reduction in liver cholesterol concentration and suggests that the green tea extract was able to increase the efflux of cholesterol from liver cells.

Keywords

Green tea LDL receptor Cholesterol synthesis Cholesterol absorption Lathosterol Phytosterols 

Notes

Acknowledgments

We would like to thank the University of Adelaide for providing Christina Bursill with a postgraduate scholarship and additional funding.

References

  1. 1.
    Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34–47PubMedCrossRefGoogle Scholar
  2. 2.
    Glass CK, Witztum JL (2001) Atherosclerosis: the road ahead. Cell 104:503–516PubMedCrossRefGoogle Scholar
  3. 3.
    Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K (1992) Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Prev Med 21:526–531PubMedCrossRefGoogle Scholar
  4. 4.
    Stensvold I, Tverdal A, Solvoll K, Foss OP (1992) Tea consumption: relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 21:546–553PubMedCrossRefGoogle Scholar
  5. 5.
    Imai K, Nakachi K (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310:693–696PubMedGoogle Scholar
  6. 6.
    Muramatsu K, Fukuyo M, Hara Y (1986) Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo) 32:613–622Google Scholar
  7. 7.
    Matsuda H, Chisaka T, Kubomura Y, Yamahara J, Sawada T, Fujimura H, Kimura H (1986) Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J Ethnopharmacol 17:213–224PubMedCrossRefGoogle Scholar
  8. 8.
    Yang TT, Koo MW (1997) Hypocholesterolemic effects of Chinese tea. Pharmacol Res 35:505–512PubMedCrossRefGoogle Scholar
  9. 9.
    Anonymous (2000) Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci 66:411–423Google Scholar
  10. 10.
    Chan PT, Fong WP, Cheung YL, Huang Y, Ho WK, Chen ZY (1999) Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 129:1094–1101PubMedGoogle Scholar
  11. 11.
    Bursill C, Roach PD, Bottema CD, Pal S (2001) Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells. J Agric Food Chem 49:5639–5645PubMedCrossRefGoogle Scholar
  12. 12.
    Bursill CA, Roach PD (2006) Modulation of cholesterol metabolism by the green tea polyphenol (−)-epigallocatechin gallate in cultured human liver (HepG2) cells. J Agric Food Chem 54:1621–1626PubMedCrossRefGoogle Scholar
  13. 13.
    Kuhn DJ, Burns AC, Kazi A, Dou QP (2004) Direct inhibition of the ubiquitin–proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor. Biochim Biophys Acta 1682:1–10PubMedGoogle Scholar
  14. 14.
    Chisaka T, Matsuda H, Kubomura Y, Mochizuki M, Yamahara J, Fujimura H (1988) The effect of crude drugs on experimental hypercholesteremia: mode of action of (−)-epigallocatechin gallate in tea leaves. Chem Pharm Bull (Tokyo) 36:227–233Google Scholar
  15. 15.
    Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo T, Yayabe F, Sugano M (1992) Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1127:141–146PubMedGoogle Scholar
  16. 16.
    Bursill CA, Abbey M, Roach PD (2007) A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193:86–93PubMedCrossRefGoogle Scholar
  17. 17.
    Huang MT, Ho CT, Wang ZY, Ferraro T, Finnegan-Olive T, Lou YR, Mitchell JM, Laskin JD, Newmark H et al (1992) Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 13:947–954PubMedCrossRefGoogle Scholar
  18. 18.
    Clifton PM, Chang L, Mackinnon AM (1988) Development of an automated Lowry protein assay for the Cobas-Bio centrifugal analyser. Anal Biochem 172:165–168PubMedCrossRefGoogle Scholar
  19. 19.
    Wolthers BG, Walrecht HT, van der Molen JC, Nagel GT, Van Doormaal JJ, Wijnandts PN (1991) Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. J Lipid Res 32:603–612PubMedGoogle Scholar
  20. 20.
    Kempen HJ, Glatz JF, Gevers Leuven JA, van der Voort HA, Katan MB, (1988) Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 29:1149–1155PubMedGoogle Scholar
  21. 21.
    Tilvis RS, Miettinen TA (1986) Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 43:92–97PubMedGoogle Scholar
  22. 22.
    Roach PD, Zollinger M, Noel SP (1987) Detection of the low density lipoprotein (LDL) receptor on nitrocellulose paper with colloidal gold–LDL conjugates. J Lipid Res 28:1515–1521PubMedGoogle Scholar
  23. 23.
    Roach PD, Noel SP (1985) Solubilization of the 17 alpha-ethinyl estradiol-stimulated low density lipoprotein receptor of male rat liver. J Lipid Res 26:713–720PubMedGoogle Scholar
  24. 24.
    Roach PD, Kerry NL, Whiting MJ, Nestel PJ (1993) Coordinate changes in the low density lipoprotein receptor activity of liver and mononuclear cells in the rabbit. Atherosclerosis 101:157–164PubMedCrossRefGoogle Scholar
  25. 25.
    Grundy SM (1991) George Lyman Duff memorial lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease. Arterioscler Thromb 11:1619–1635PubMedGoogle Scholar
  26. 26.
    Albertini R, Moratti R, De Luca G (2002) Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr Mol Med 2:579–592PubMedCrossRefGoogle Scholar
  27. 27.
    Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963–20966PubMedCrossRefGoogle Scholar
  28. 28.
    Ohashi R, Mu H, Wang X, Yao Q, Chen C (2005) Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 98:845–856PubMedCrossRefGoogle Scholar
  29. 29.
    Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S) (1994) Lancet 344:1383–1389Google Scholar
  30. 30.
    MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial (2002) Lancet 360:7–22Google Scholar
  31. 31.
    Roach PD BS, Hirata F, Abbey M, Szanto A, Simons LA, Nestel PJ (1993) The low-density lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat. Biochim Biophys Acta 1170(2):165–172PubMedGoogle Scholar
  32. 32.
    Wang S, Noh SK, Koo SI (2006) Epigallocatechin gallate and caffeine differentially inhibit the intestinal absorption of cholesterol and fat in ovariectomized rats. J Nutr 136(11):2791–2796PubMedGoogle Scholar
  33. 33.
    Cornelis MC, El-Sohemy A (2007) Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol 18(1):13–9PubMedCrossRefGoogle Scholar

Copyright information

© AOCS 2007

Authors and Affiliations

  1. 1.Heart Research InstituteUniversity of SydneyCamperdownAustralia
  2. 2.Applied Sciences, School of Environmental and Life SciencesThe University of NewcastleOurimbahAustralia
  3. 3.CSIRO Human NutritionAdelaideAustralia
  4. 4.University of AdelaideAdelaideAustralia

Personalised recommendations